Health Care: Drugs

Cytori Therapeutics Inc (CYTX: NASDAQ)

$1.06 -0.04 | -3.64%
04/25/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 11.38M 11.66M 7.60M 12.20M
Cost of Sales 555.00K 749.00K 362.00K 694.00K
Gross Operating Profit 10.82M 10.91M 7.24M 11.50M
Selling, General, and Administrative Expenses 12.17M 12.43M 22.36M 25.06M
Research & Development 16.20M 19.00M 15.11M 17.07M
Operating Income before D & A (EBITDA) -17.55M -20.52M -30.23M -30.62M
Depreciation & Amortization 2.16M 2.44M 2.58M 2.73M
Interest Income 19.00K 9.00K 6.00K 4.00K
Other Income - Net 233.00K -88.00K -566.00K 3.05M
Special Income / Charges 0.00 7.67M 369.00K 2.67M
Total Income Before Interest Expenses (EBIT) -19.45M -15.37M -33.00M -22.78M
Interest Expense 2.59M 3.38M 4.37M 3.40M
Pre-Tax Income -22.05M -18.74M -37.37M -26.18M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -22.05M -18.74M -37.37M -26.18M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -22.05M -18.74M -37.37M -26.18M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -22.05M -18.74M -37.37M -26.18M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-22.05M -26.41M -37.74M -28.84M
Preferred Dividends
Net Income Available To Common -22.05M -19.41M -38.54M -26.18M
Basic EPS from Continuing Ops. -1.28 -2.07 -7.20 -5.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.28 -2.07 -7.20 -5.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.28 -2.07 -7.20 -5.85
Basic Normalized Net Income/Share -1.28 -2.92 -7.27 -6.45
EPS fr Continuing Ops. -1.28 -2.07 -7.20 -5.85
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.28 -2.07 -7.20 -5.85
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.28 -2.07 -7.20 -5.85
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.28 -2.92 -7.27 -6.45
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CYTX

Latest CYTX Headlines from TheStreet

More Financial News for CYTX

Press Releases for CYTX

See All Press Releases

Partner Headlines for CYTX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter